Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes

European Journal of Pharmacology

Volumn 516, Issue 1, 2005, Pages 28-33

  Gorzalka, Boris B ^a   Hill, Matthew N ^a   Sun, Jane C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

(Rat); 5 HT2A; Alpha amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid (AMPA); Endocannabinoid; Kainate; Wet dog shake

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; KETANSERIN; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WET DOG SHAKES;

AMPHETAMINES; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; KETANSERIN; MALE; PIPERIDINES; PYRAZOLES; QUINOXALINES; RATS; RATS, LONG-EVANS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; SEROTONIN AGONISTS;

EID: 20344396334     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.04.019     Document Type: Article

References (40)

1. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their functions Neuropharmacology 38 1999 1083 1152
2. K.A. Berg, S. Maayani, and W.P. Clarke Interactions between effectors linked to serotonin receptors Ann. N.Y. Acad. Sci. 861 1998 111 120
3. E.M. Berry, and R. Mechoulam Tetrahydrocannabinol and endocannabinoids in feeding and appetite Pharmacol. Ther. 95 2002 185 190
4. T. Bisogno, F. Howell, G. Williams, A. Minassi, M.G. Cascio, A. Ligresti, I. Matias, A. Schiano-Moriello, P. Paul, E.J. Williams, U. Gangadharan, C. Hobbs, V. Di Marzo, and P. Doherty Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain J. Cell Biol. 163 2004 463 468
5. J.F. Cheer, A.K. Cadogan, C.A. Marsden, K.C. Fone, and D.A. Kendall Modification of 5-HT2 receptor mediated behavior in the rat by oleamide and the role of cannabinoid receptors Neuropharmacology 38 1999 533 541
6. R.Z. Chen, R.R. Huang, C.P. Shen, D.J. MacNeil, and T.M. Fong Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice Brain Res. 999 2004 227 230
7. B. Costa, G. Giagnoni, and M. Colleoni Precipitated and spontaneous withdrawal in rats tolerant to anandamide Psychopharmacology 149 2000 121 128
8. N.A. Darmani Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice Pharmacol. Biochem. Behav. 68 2001 311 317
9. N.A. Darmani, and B. Ahmad Long-term sequential determination of behavioral ontogeny of 5-HT1A and 5-HT2 receptor functions in the rat J. Pharmacol. Exp. Ther. 288 1999 247 253
10. N.A. Darmani, and D.K. Pandya Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR141716 in naïve mice J. Neural Transm. 107 2000 931 945
11. N.A. Darmani, B.R. Martin, U. Pandey, and R.A. Glennon Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol. Biochem. Behav. 36 1990 901 906
12. L. de Angelis 5-HT2A antagonists in psychiatric disorders Curr. Opin. Investig. Drugs 3 2002 106 112
13. N. Egashira, K. Mishima, T. Uchida, N. Hasebe, H. Nagai, A. Mizuki, K. Iwasaki, H. Ishii, R. Nishimura, Y. Shoyama, and M. Fujiwara Anandamide inhibits the DOI-induced head twitch response in mice Psychopharmacology 171 2004 382 389
14. A. Giuffrida, F. Rodriguez de Fonseca, F. Nava, P. Loubet-Lescoulie, and D. Piomelli Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404 Eur. J. Pharmacol. 408 2000 161 168
15. G.M. Goodwin, A.R. Green, and P. Johnson 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head twitch behavior following antidepressant treatment to mice Br. J. Pharmacol. 83 1984 235 242
16. B.B. Gorzalka, and L.A. Hanson Sexual behavior and wet dog shakes in the male rat: regulation by corticosterone Behav. Brain Res. 97 1998 143 151
17. B.B. Gorzalka, L.A. Hanson, and J.J. Hong Ketanserin attenuates the behavioural effects of corticosterone: implications for 5-HT(2A) receptor regulation Eur. J. Pharmacol. 428 2001 235 240
18. F.G. Graeff, F.S. Guimares, T.G. De Andrade, and J.F. Deakin Role of 5-HT in stress, anxiety and depression Pharmacol. Biochem. Behav. 54 1996 129 141
19. N. Hajos, and T.F. Freund Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers Neuropharmacology 43 2002 503 510
20. S.R. Hettes, J. Gonzaga, T.W. Heyming, S. Perez, S. Wolfsohn, and B.G. Stanley Dual roles in feeding for AMPA/kainate receptors: receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior Brain Res. 992 2003 167 178
21. H.S. Kim, I.S. Park, and W.K. Park NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in mice Life Sci. 63 1998 2305 2311
22. T. Kimura, T. Ohta, K. Watanabe, H. Yoshimura, and I. Yamamoto Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor Biol. Pharm. Bull. 21 1998 224 226
23. S.J. Kitchener, and C.T. Dourish An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats Psychopharmacology 113 1994 369 377
24. I. Lastres-Becker, R. de Miguel, L. De Petrocellis, A. Makriyannis, V. Di Marzo, and J. Fernandez-Ruiz Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease J. Neurochem. 84 2003 1097 1109
25. I. Lastres-Becker, H.H. Hansen, F. Berrendero, R. De Miguel, A. Perez-Rosado, J. Manzanares, J.A. Ramos, and J. Fernandez-Ruiz Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease Synapse 44 2002 23 35
26. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, A. Cannich, S.C. Azad, M.G. Cascio, S.O. Gutierrez, M. van der Stelt, M.L. Lopez-Rodriguez, E. Casanova, G. Schutz, W. Zieglgansberger, V. Di Marzo, C. Behl, and B. Lutz CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
27. K. Matsumoto, M. Mizowaki, S. Thongpraditchote, Y. Murakami, and H. Watanabe Alpha2-adrenoreceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice Pharmacol. Biochem. Behav. 56 1997 417 422
28. C. Molla-Hosseini, P.M. Lenicque, J. Wepierre, and Y. Cohen Behavior and kainic acids differential behavioral and biochemical effects of kainic acid and allokainic acid injections in rats J. Pharmacol. 16 1985 191 196
29. M. Nakazi, U. Bauer, T. Nickel, M. Kathmann, and E. Schlicker Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 361 2000 19 24
30. R.C. Pierce, W.M. Meil, and P.W. Kalivas The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission Psychopharmacology 133 1997 188 195
31. V. Raghavendra, and S.K. Kulkarni Melatonin reversal of DOI-induced hypophagia in rats: possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis Brain Res. 860 2000 112 118
32. T. Rubino, D. Vigano, E. Zagato, M. Sala, and D. Parolaro In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments Synapse 35 2000 8 14
33. R. Schreiber, M. Brocco, V. Audinot, A. Gobert, S. Veiga, and M.J. Millan (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists J. Pharmacol. Exp. Ther. 273 1995 101 112
34. J.L. Scruggs, S. Patel, M. Bubser, and A.Y. Deutch DOI-induced activation of the cortex: dependence on 5-HT2A heteroreceptors on thalamocortical glutamatergic neurons J. Neurosci. 20 2000 8846 8852
35. M. Shen, T.M. Piser, V.S Seybold, and S.A. Thayer Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures J. Neurosci. 16 1996 4322 4334
36. O. Spigset, T. Andersen, S. Hagg, and T. Mjondal Enhanced platelet serotonin 5-HT2A receptor binding in anorexia nervosa and bulimia nervosa Eur. Neuropsychopharmacol. 9 1999 469 473
37. M. Steffens, and T.J. Feuerstein Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex-involvement of Na(+)/K(+)-ATPase Neurochem. Int. 44 2004 529 538
38. E.T. Tzavara, R.J. Davis, K.W. Perry, X. Li, C. Salhoff, F.P. Bymaster, J.M. Witkin, and G.G. Nomikos The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions Br. J. Pharmacol. 138 2003 544 553
39. N.V. Watson, and B.B. Gorzalka Relation of spontaneous wet dog shakes and copulatory behavior in male rats Pharmacol. Biochem. Behav. 37 1990 825 829
40. C.Y. Yap, and D.A. Taylor Involvement of 5-HT2 receptors in the wet-dog shake behavior induced by administration of 5-hydroxytryptophan Neuropharmacology 22 1983 801 804